Reimagining the landscape of therapeutic innovation, pharmaceutical biotechnology & drug discovery leverages molecular biology, genomics, and cell culture systems to create next-generation biopharmaceuticals. Monoclonal antibodies, recombinant proteins, and RNA-based therapies are now pivotal in treating complex diseases, including cancer and autoimmune disorders. High-throughput screening, structure-based drug design, and bioinformatics platforms expedite the identification of potent drug candidates. In Pharmaceutical Biotechnology & Drug Discovery, personalized medicine is also gaining traction through biomarkers and companion diagnostics, enabling tailored treatments. Furthermore, biotechnology enhances drug delivery via nanocarriers and controlled-release systems, improving efficacy and patient compliance. This evolving field plays a central role in shaping modern healthcare, offering precision, safety, and scalability in therapeutic development.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States